Trinity Biotech ( ($TRIB) ) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous ...

Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq ...

Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...

Trinity Biotech (TRIB) stock gains on encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose ...

Relative return is the difference between the absolute return and the performance ... What Does Alpha Mean to Investors? Alpha (α) is a term used in investing to describe an investment strategy ...

Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring ...

PFÄFFIKON, CH / ACCESS Newswire / January 30, 2025 / Liom has now released the results of one of its external clinical ...

and breakthrough accuracy with a 25-30% improvement in mean absolute relative difference (MARD), a critical accuracy metric. The system also achieved industry-standard precision for low-glucose ...